Henry Joseth González-Torres

Prof. Henry Joseth González-Torres

Facultad de Ciencias de la Salud, Universidad Simón Bolívar, Barranquilla, Atlántico, Colombia
orcid
Bio., Spec. App. Stat., M.Sc. Bio. (GenPop), Dr.Sc. BioMed. ...

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
JRJoselyn Rojas-Quintero
Joselyn Rojas-Quintero
MDMaría P. Díaz
María P. Díaz
JBJim Jose Palmar Barreto
Jim Jose Palmar Barreto
NGNataly Galan-Freyle
Nataly Galan-Freyle
VMValery Morillo
Valery Morillo
VBValmore Bermudez
Valmore Bermudez
Chimeric antigen receptor T cell (CAR T cell) therapy has emerged as a prominent adoptive cell therapy and a therapeutic approach of great interest in the fight against cancer. This approach has shown notorious efficacy in refractory hematological neoplasm, which has bolstered its exploration in the field of solid cancers. However, successfully managing solid tumors presents considerable intrinsic challenges, which include the necessity of guiding the modified cells toward the tumoral region, assuring their penetration and survival in adverse microenvironments, and addressing the complexity of identifying the specific antigens for each type of cancer. This review focuses on outlining the challenges faced by CAR T cell therapy when used in the treatment of solid tumors, as well as presenting optimizations and emergent approaches directed at improving its efficacy in this particular context. From precise localization to the modulation of the tumoral microenvironment and the adaptation of antigen recognition strategies, diverse pathways will be examined to overcome the current limitations and buttress the therapeutic potential of CAR T cells in the fight against solid tumors.

14 November 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
Elkin Navarro QuirozElkin Navarro Quiroz
Elkin Navarro Quiroz
LPLisandro Alfonso Pacheco
Lisandro Alfonso Pacheco
roberto carlos quirozroberto carlos quiroz
roberto carlos quiroz
HLHernan A Lorenzi
Hernan A Lorenzi
PEPierine España-Puccini
Pierine España-Puccini
GAGustavo Aroca
Gustavo Aroca
Renal involvement in Systemic Lupus Erythematous (SLE) patients is one of the leading causes of morbidity and a significant contributor to mortality. It’s estimated that nearly 50% of SLE individuals develop kidney disease in the first year of the diagnosis. Class IV lupus nephritis (LN-IV) is the class of lupus nephritis most common in Colombian patients with SLE. Altered miRNAs expression levels have been reported in human autoimmune diseases including lupus. Variations in the expression pattern of peripheral blood circulating miRNAs specific for this class of lupus nephritis could be correlated with the pathophysiological status of this group of individuals. The aim of this study was to evaluate the relative abundance of circulating microRNAs in peripheral blood from Colombian patients with LN-IV. Circulating miRNAs in plasma of patients with diagnosis of LN-IV were compared with individuals without renal involvement (LNN group) and healthy individuals (CTL group). Total RNA was extracted from 10 ml of venous blood and subsequently sequenced using Illumina. The sequences were processed and these were analyzed using miRBase and Ensembl databases. Differential gene expression analysis was carried out with edgeR and functional analysis were done with DIANA-miRPath. Analysis was carried out using as variables of selection fold change (≥2 o ≤-2) and false discovery rate (0.05). We identified 24 circulating microRNAs with differential abundance between LN-IV and CTL groups, fourteen of these microRNAs are described for the first time to lupus nephritis (hsa-miR-589-3p, hsa-miR-1260b, hsa-miR-4511, hsa-miR-485-5p, hsa-miR-584-5p, hsa-miR-543, hsa-miR-153-3p, hsa-miR-6087, hsa-miR-3942-5p, hsa-miR-7977, hsa-miR-323b-3p, hsa-miR-4732-3p and hsa-miR-6741-3p). These changes in the abundance of miRNAs could be interpreted as alterations in the miRNAs-mRNA regulatory network in the pathogenesis of LN, preceding the clinical onset of the disease. The findings thus contribute to understanding the disease process and are likely to pave the way towards identifying disease biomarkers for early diagnosis of LN.

19 November 2018 in Lupus
Verified
Journal Article
Closed access
LPLisandro Alfonso Pacheco
Lisandro Alfonso Pacheco
JSJ. Sáenz-García
J. Sáenz-García
Elkin Navarro QuirozElkin Navarro Quiroz
Elkin Navarro Quiroz
Henry Joseth González-TorresHenry Joseth González-Torres
Henry Joseth González-Torres
LFL. Fang
L. Fang
GAGustavo Aroca
Gustavo Aroca
Background: Systemic lupus erythematosus is a heterogeneous chronic inflammatory autoimmune disorder characterized by an exacerbated expression of cytokines and chemokines in different tissues and organs. Renal involvement is a significant contributor to the morbidity and mortality of systemic lupus erythematosus, and its diagnosis is based on renal biopsy, an invasive procedure with a high risk of complications. Therefore, the development of alternative, non-invasive diagnostic tests for kidney disease in patients with systemic lupus erythematosus is a priority. Aim: To evaluate the plasma levels of a panel of cytokines and chemokines using multiplex xMAP technology in a cohort of Colombian patients with active and inactive systemic lupus erythematosus, and to evaluate their potential as biomarkers of renal involvement. Results: Plasma from 40 systemic lupus erythematosus non-nephritis patients and 80 lupus nephritis patients with different levels of renal involvement were analyzed for 39 cytokines using Luminex xMAP technology. Lupus nephritis patients had significantly increased plasma eotaxin, TNF-α, interleukin-17-α, interleukin-10, and interleukin-15 as compared to the systemic lupus erythematosus non-nephritis group. Macrophage-derived chemokine, growth regulated oncogene alpha, and epidermal growth factor were significantly elevated in systemic lupus erythematosus non-nephritis patients when compared to lupus nephritis individuals. Plasma eotaxin levels allowed a discrimination between systemic lupus erythematosus non-nephritis and lupus nephritis patients, for which we performed a receiver operating characteristic curve to confirm. We observed a correlation of eotaxin levels with active nephritis (Systemic Lupus Erythematosus Disease Activity Index). Our data indicate that circulating cytokines and chemokines could be considered good predictors of renal involvement in individuals with systemic lupus erythematosus.

1 December 2019 in International Journal of Nephrology and Renovascular Disease
Verified
Journal Article
Open access
PDF file
MRMaria A Risso
Maria A Risso
SSSofía Sallustio
Sofía Sallustio
VSValentin Sueiro
Valentin Sueiro
VBVictoria Bertoni
Victoria Bertoni
Henry Joseth González-TorresHenry Joseth González-Torres
Henry Joseth González-Torres
CMCarlos G. Musso
Carlos G. Musso
Glomerular filtration rate (GFR) and proteinuria-albuminuria are the renal functional parameters currently used to evaluate chronic kidney disease (CKD) severity. However, tubular secretion is another important renal functional parameter to be taken into account since proximal tubule (PT) secretion, in particular, is a crucial renal mechanism for endogenous organic cations, anions and drug elimination. The residual diuresis is a relevant survival predictor in patients on dialysis, since their urine is produced by the glomerular and tubular functions. It has been hypothesized that drugs which up-regulate some renal tubular transporters could contribute to uremic toxin excretion, and nephroprevention. However, if tubular transporters’ down-regulation observed in CKD patients and experimental models is a PT adaptation to avoid intracellular accumulation and damage from uremic toxins, consequently the increase of toxin removal by inducing tubular transporters’ up-regulation could be deleterious to the kidney. Therefore, a deeper understanding of this phenomenon is currently needed. In conclusion, tubular function has an important role for endogenous organic cations, anions and drug excretion in CKD patients, and a deeper understanding of its multiple mechanisms could provide new therapeutic alternatives in this population.

Verified
Journal Article
Open access
PDF file
Elkin Navarro QuirozElkin Navarro Quiroz
Elkin Navarro Quiroz
Valeria Chavez-EstradaValeria Chavez-Estrada
Valeria Chavez-Estrada
KMKarime Macias-Ochoa
Karime Macias-Ochoa
María Fernanda Ayala NavarroMaría Fernanda Ayala Navarro
María Fernanda Ayala Navarro
AFAniyensy Sarai Flores-Aguilar
Aniyensy Sarai Flores-Aguilar
roberto carlos quirozroberto carlos quiroz
roberto carlos quiroz
The complex physiology of eukaryotic cells is regulated through numerous mechanisms, including epigenetic changes and posttranslational modifications. The wide-ranging diversity of these mechanisms constitutes a way of dynamic regulation of the functionality of proteins, their activity, and their subcellular localization as well as modulation of the differential expression of genes in response to external and internal stimuli that allow an organism to respond or adapt to accordingly. However, alterations in these mechanisms have been evidenced in several autoimmune diseases, including systemic lupus erythematosus (SLE). The present review aims to provide an approach to the current knowledge of the implications of these mechanisms in SLE pathophysiology.

22 August 2018 in Emerging Microbes & Infections
Verified
Journal Article
Open access
PDF file
Aileen ChangAileen Chang
Aileen Chang
RLRebecca Lynch
Rebecca Lynch
KMKaren Martins
Karen Martins
LELiliana Encinales
Liliana Encinales
ABAndrés Á. Cadena Bonfanti
Andrés Á. Cadena Bonfanti
GSGary L. Simon
Gary L. Simon